Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm

Neuroscience Research

Volumn 71, Issue 3, 2011, Pages 219-225

  Malomouzh, Artem I ^a   Nikolsky, Eugeny E ^a,b   Vyskočil, František ^c,d  

^a KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Acetylcholine; ATP; Glutamate; Neuromuscular junction; Nitric oxide; Non quantal release; P2Y receptors; Phospholipase C

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ADENOSINE TRIPHOSPHATE; CHOLINESTERASE; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; NICOTINIC RECEPTOR; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; SURAMIN; VOLTAGE GATED CALCIUM CHANNEL;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERPOLARIZATION; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANIMALS; DIAPHRAGM; DRUG SYNERGISM; FEMALE; GLUTAMIC ACID; H-REFLEX; MALE; MOTOR NEURONS; NERVE ENDINGS; NEUROMUSCULAR JUNCTION; PURINERGIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; RECEPTORS, PURINERGIC P2Y; SYNAPTIC TRANSMISSION;

EID: 80053219705     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.07.1829     Document Type: Article

References (56)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., Weisman G.A. International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 2006, 58:281-341.
2. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 2009, 32:19-29.
3. Abramochkin D.V., Nurullin L.F., Borodinova A.A., Tarasova N.V., Sukhova G.S., Nikolsky E.E., Rosenshtraukh L.V. Non-quantal release of acetylcholine from parasympathetic nerve terminals in the right atrium of rats. Exp. Physiol. 2010, 95:265-273.
4. Adamek S., Shakirzyanova A.V., Malomouzh A.I., Naumenko N.V., Vyskočil F. Interaction of glutamate- and adenosine-induced decrease of acetylcholine quantal release at frog neuromuscular junction. Physiol. Res. 2010, 59:803-810.
5. Bhardwaj A., Northington F.J., Martin L.J., Hanley D.F., Traystman R.J., Koehler R.C. Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo. J. Cerebr. Blood Flow Metab. 1997, 17:153-160.
6. Buchthal F., Folkow B. Interaction between acetylcholine and adenosine triphosphate in normal, curarised and denervated muscle. Acta Physiol. Scand. 1948, 15:150-160.
7. Bultmann R., Dudeck O., Starke K. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli. Naunyn Schmiedebergs. Arch. Pharmacol. 1996, 353:445-451.
8. Bultmann R., Trendelenburg M., Tuluc F., Wittenburg H., Starke K. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens. Naunyn Schmiedebergs. Arch. Pharmacol. 1999, 359:339-344.
9. Burnstock G. Cotransmission. Curr. Opin. Pharmacol. 2004, 4:47-52.
10. Burnstock G. Introduction: P2 receptors. Curr. Top. Med. Chem. 2004, 4:793-803.
11. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007, 87:659-797.
12. Burnstock G. Purine and pyrimidine receptors. Cell. Mol. Life Sci. 2007, 64:1471-1483.
13. Chizh B.A., Illes P. P2X receptors and nociception. Pharmacol. Rev. 2001, 53:553-568.
14. Costa M.A., Elesgaray R., Caniffi C., Fellet A., Arranz C. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects. Biochem. Biophys. Res. Commun. 2007, 359:180-186.
15. De Lorenzo S., Veggetti M., Muchnik S., Losavio A. Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction. Neuroscience 2006, 142:71-85.
16. Doležal V., Vyskočil F., Tuček S. Decrease of the spontaneous non-quantal release of acetylcholine from the phrenic nerve in botulinum-poisoned rat diaphragm. Pflug. Arch. 1983, 397:319-322.
17. Edwards C., Doležal V., Tuček S., Zemková H., Vyskočil F. Is an acetylcholine transport system responsible for nonquantal release of acetylcholine at the rodent myoneural junction?. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:3514-3518.
18. Galkin A.V., Giniatullin R.A., Mukhtarov M.R., Svandova I., Grishin S.N., Vyskočil F. ATP but not adenosine inhibits nonquantal acetylcholine release at the mouse neuromuscular junction. Eur. J. Neurosci. 2001, 13:2047-2053.
19. Giniatullin R.A., Sokolova E.M. ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors. Br. J. Pharmacol. 1998, 124:839-844.
20. Grozdanovic Z., Baumgarten H.G. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. Histol. Histopathol. 1999, 14:243-256.
21. Harada N. Role of nitric oxide on purinergic signalling in the cochlea. Purinergic Signal. 2010, 6:211-220.
22. Hartzell H.C., Kuffler S.W., Yoshikami D. The number of acetylcholine molecules in a quantum and the interaction between quanta at the subsynaptic membrane of the skeletal neuromuscular synapse. Cold Spring Harb. Symp. Quant. Biol. 1976, 40:175-186.
23. Jia M., Li M.X., Fields R.D., Nelson P.G. Extracellular ATP in activity-dependent remodeling of the neuromuscular junction. Dev. Neurobiol. 2007, 67:924-932.
24. Jones R., Vyskočil F. An electrophysiological examination of the changes in skeletal muscle fibres in response to degenerating nerve tissue. Brain Res. 1975, 88:309-317.
25. Katz B., Miledi R. Transmitter leakage from motor nerve endings. Proc. R. Soc. Lond. B Biol. Sci. 1977, 196:59-72.
26. Katz E., Ferro P.A., Weisz G., Uchitel O.D. Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J. Physiol. 1996, 497:687-697.
27. Kusner L.L., Kaminski H.J. Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res. 1996, 730:238-242.
28. Liou J.C., Kang K.H., Chang L.S., Ho S.Y. Mechanism of beta-bungarotoxin in facilitating spontaneous transmitter release at neuromuscular synapse. Neuropharmacology 2006, 51:671-680.
29. Lupa M.T., Tabti N., Thesleff S., Vyskočil F., Yu S.P. The nature and origin of calcium-insensitive miniature end-plate potentials at rodent neuromuscular junctions. J. Physiol. 1986, 381:607-618.
30. Maeno-Hikichi Y., Polo-Parada L., Kastanenka K.V., Landmesser L.T. Frequency-dependent modes of synaptic vesicle endocytosis and exocytosis at adult mouse neuromuscular junctions. J. Neurosci. 2011, 31:1093-1105.
31. Malomouzh A.I., Mukhtarov M.R., Nikolsky E.E., Vyskočil F. Muscarinic M1 acetylcholine receptors regulate the non-quantal release of acetylcholine in the rat neuromuscular junction via NO-dependent mechanism. J. Neurochem. 2007, 102:2110-2117.
32. Malomouzh A.I., Mukhtarov M.R., Nikolsky E.E., Vyskočil F., Lieberman E.M., Urazaev A.K. Glutamate regulation of non-quantal release of acetylcholine in the rat neuromuscular junction. J. Neurochem. 2003, 85:206-213.
33. Malomouzh A.I., Nikolsky E.E. Non-quantal acetylcholine release in the mammalian neuromuscular junction: dependence on the extracellular concentration of magnesium and calcium ions. Dokl. Biol. Sci. 2010, 430:8-10.
34. Malomouzh A.I., Nikolsky E.E., Lieberman E.M., Sherman J.A., Lubischer J.L., Grossfeld R.M., Urazaev A.Kh. Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat. J. Neurochem. 2005, 94:257-267.
35. Mukhtarov M.R., Urazaev A.K., Nikolskii E.E., Vyskočil F. Modulation by nitric oxide (NO) of the intensity of non-quantum mediator secretion in neuromuscular junctions in rats. Neurosci. Behav. Physiol. 2001, 31:451-455.
36. Mukhtarov M.R., Urazaev A.K., Nikolsky E.E., Vyskočil F. Effect of nitric oxide and NO synthase inhibition on nonquantal acetylcholine release in the rat diaphragm. Eur. J. Neurosci. 2000, 12:980-986.
37. Mukhtarov M.R., Vyskočil F., Urazaev A.K., Nikolsky E.E. Non-quantal acetylcholine release is increased after nitric oxide synthase inhibition. Physiol. Res. 1999, 48:315-317.
38. Nikolsky E.E., Voronin V.A., Oranska T.I., Vyskočil F. The dependence of non-quantal acetylcholine release on the choline-uptake system in the mouse diaphragm. Pflug. Arch. 1991, 418:74-78.
39. Nishimaru H., Restrepo C.E., Ryge J., Yanagawa Y., Kiehn O. Mammalian motor neurons corelease glutamate and acetylcholine at central synapses. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5245-5249.
40. Pardi D., Margiotta J.F. Pituitary adenylate cyclase-activating polypeptide activates a phospholipase C-dependent signal pathway in chick ciliary ganglion neurons that selectively inhibits alpha7-containing nicotinic receptors. J. Neurosci. 1999, 19:6327-6337.
41. Petrov A.M., Naumenko N.V., Uzinskaya K.V., Giniatullin A.R., Urazaev A.K., Zefirov A.L. Increased non-quantal release of acetylcholine after inhibition of endocytosis by methyl-β-cyclodextrin: the role of vesicular acetylcholine transporter. Neuroscience 2011, 186:1-12.
42. Porter V.A., Wray D. Relative potencies of metal ions on transmitter release at mouse motor nerve terminals. Br. J. Pharmacol. 1996, 118:27-32.
43. Protti D.A., Szczupak L., Scornik F.S., Uchitel O.D. Effect of omega-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction. Brain Res. 1991, 557:336-339.
44. Ribeiro J.A., Cunha R.A., Correia-de-Sa P., Sebastiao A.M. Purinergic regulation of acetylcholine release. Prog. Brain Res. 1996, 109:231-241.
45. Silinsky E.M., Redman R.S. Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J. Physiol. 1996, 492:815-822.
46. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81:209-237.
47. Volknandt W., Zimmermann H. Acetylcholine, ATP, and proteoglycan are common to synaptic vesicles isolated from the electric organs of electric eel and electric catfish as well as from rat diaphragm. J. Neurochem. 1986, 47:1449-1462.
48. Vyas S., Bradford H.F. Co-release of acetylcholine, glutamate and taurine from synaptosomes of Torpedo electric organ. Neurosci. Lett. 1987, 82:58-64.
49. Vyskočil F. Early postdenervation depolarization is controlled by acetylcholine and glutamate via nitric oxide regulation of the chloride transporter. Neurochem. Res. 2003, 28:575-585.
50. Vyskočil F., Illes P. Non-quantal release of transmitter at mouse neuromuscular junction and its dependence on the activity of Na+-K+ ATP-ase. Pflug. Arch. 1977, 370:295-297.
51. Vyskočil F., Illés P. Electrophysiological examination of transmitter release in non-quantal form in the mouse diaphragm and the activity of membrane ATP-ase. Physiol. Bohemoslov. 1978, 27:449-455.
52. Vyskočil F., Malomouzh A.I., Nikolsky E.E. Non-quantal acetylcholine release at the neuromuscular junction. Physiol. Res. 2009, 58:763-784.
53. Vyskočil F., Nikolsky E., Edwards C. An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the mouse neuromuscular junction. Neuroscience 1983, 9:429-435.
54. Vyskočil F., Vrbova G. Non-quantal release of acetylcholine affects polyneuronal innervation on developing rat muscle fibres. Eur. J. Neurosci. 1993, 5:1677-1683.
55. Wittenburg H., Bultmann R., Pause B., Ganter C., Kurz G., Starke K. P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue. Naunyn Schmiedebergs. Arch. Pharmacol. 1996, 354:491-497.
56. 2+ on non-quantal acetylcholine release at the mouse neuromuscular junction. Neurosci. Lett. 1989, 103:293-297.